Thursday, November 01, 2007

Antibiotic accelerates tragic Lou Gehrig's disease, says study
AFP -
The drug, minocycline, was tested on human volunteers with amyotrophic lateral sclerosis (ALS), as Lou Gehrig's is called, and doctors are testing it on ...
See all stories on this topic

This Is MS Forums - New causes of neurodegeneration | Unbiased ...
Get started by sharing your Multiple Sclerosis story. ... In both cases the levels of PI(3,5)P2 are one half of the normal levels. ...

MS Trust | News
Multiple Sclerosis Trust - UK charity providing information for people with MS, ... The molecule PI(3,5)P2 is a lipid found in all cells at very low levels. ...
Imperial - Tissue Engineering and Regenerative Medicine
Regenerative Medicine, Tissue Engineering and associated disciplines at Imperial .... glial progenitors implanted in various models: (Multiple Sclerosis, ...

Antisense Therapeutics to Present at Rodman & Renshaw 9th Annual ...
Market Wire (press release) - USA
The Company's current Phase iia trial is a study in 80 patients to assess the safety and efficacy of ATL1102 as a treatment for relapsing remitting MS. ...
See all stories on this topic

Magnetization transfer imaging predicts progression of disability ...
Medicexchange - London,UK
Magnetization transfer imaging (MTI) predicts deterioration in patients with primary progressive multiple sclerosis (PPMS), according to a report in the ...
See all stories on this topic

Therapy offers ray of hope for Evans City girl
Pittsburgh Tribune-Review - Pittsburgh,PA,USA
... including Alzheimer's disease, brain injury, cerebral palsy and multiple sclerosis. "Stem cells are not a cure, and I think that has to be stressed. ...
See all stories on this topic

. . . Stakes for cures too high to allow ideology to interfere
Asbury Park Press - Asbury Park,NJ,USA
... juvenile diabetes, or multiple sclerosis. When you see the stem cell research referendum (Public Question No. 2) on your ballot, you can do that. ...
See all stories on this topic

Biogen Idec Reports Third Quarter 2007 Results
Business Wire (press release) - San Francisco,CA,USA
On September 30 th , Biogen Idec announced the publication of findings from a preclinical study reporting that the anti-LINGO-1 antibody can promote spinal ...
See all stories on this topic

Scientists Use Shared Genome Data To Confirm SORL1 Gene Linked To Alzheimer's
Until recently, only one of the approximately 30,000 genes in the human genome has been linked to risk of late-onset Alzheimer's disease (AD). Now, a new NIH-supported study in the Nov. 19, 2007, issue of NeuroReport (now online) used a publicly shared genome dataset to strongly support findings that variation in the sequence of the SORL1 gene may be a second risk factor gene for late-onset disease.
31 Oct 2007

News From The Journal Of The National Cancer Institute
Cancer-Killing Virus Shows Promise as Metastatic Cancer TreatmentThe Seneca Valley Virus is a potent cancer killer and can differentiate between normal and cancerous cells. The virus may be a potential treatment for some metastatic cancers, such as small-cell lung cancer.
31 Oct 2007

Scientists Identify Chemical That Triggers Parkinson's Disease
Researchers at the Saint Louis University School of Medicine have discovered the key brain chemical that causes Parkinson's disease -- a breakthrough finding that could pave the way for new, far more effective therapies to treat one of the most common and debilitating neurological disorders.
31 Oct 2007

Study Maps The Making Of A Decision In The Human Brain
The brain, the human supercomputer, might work more like an assembly line when recognizing objects, with a hierarchy of brain regions separately absorbing and processing information before a person realizes what they are seeing, according to new research conducted at the University of Pittsburgh and published in the Oct.
31 Oct 2007

0 Comments:

Post a Comment

Links to this post:

Create a Link

<< Home